At Hadassah Ein Kerem Hospital in Jerusalem, a unique medical milestone was set this week: nine urgent patients underwent aortic valve replacement through cardiac catheterization (TAVR \u2013 Transcatheter Aortic Valve Replacement) within a single day. The procedures, performed consecutively by an experienced catheterization team, could not be delayed due to the critical condition of the patients<\/p>\n
Prof. Ofer Amir, Director of the Heart Institute at Hadassah, explained: \u201cThe accumulation of many cases in a single day reflects the constant rise in patients arriving for treatment, yet there are still many undiagnosed patients at risk. We hope that awareness and vigilance regarding heart health will increase<\/p>\n
Aortic valve replacement via cardiac catheterization offers a groundbreaking alternative to open-heart surgery, avoiding the need to open the chest. This advanced procedure enables immediate treatment for patients suffering from valve dysfunction. Hadassah has been performing such interventions for over a decade, but this week marked an extraordinary achievement \u2013 nine TAVR procedures in one day, triple the national norm<\/p>\n
The surgeries were carried out by the valve team led by Prof. David Planer and Prof. Gabi Elbaz-Griner. The aortic valve, located between the left ventricle and the aorta, plays a vital role in blood circulation. Malfunctions caused by stenosis or leakage can endanger life<\/p>\n
Prof. David Planer, Head of the Cardiac Catheterization Department, stressed: \u201cSymptomatic aortic stenosis is a life-threatening condition. Effective treatment improves symptoms and prolongs life. Rapid diagnosis and intervention are essential to prevent heart failure or sudden death. All cases that day were urgent, and the team decided to proceed with consecutive catheterizations despite the workload. The risk facing these patients was a decline in cardiac output or sudden death.\u201d He noted that even on this record-setting day, all other catheterization units continued to operate, performing elective and emergency procedures as well as complex electrophysiological interventions<\/p>\n
Prof. Gabi Elbaz-Griner, Head of the Structural Catheterization Unit, addressed international standards: \u201cIn OECD countries, an important quality measure is the waiting time between diagnosis and treatment. In North America, the average waiting time for valve replacement surgery is 42 days for elective cases and 14 days for urgent cases. There is no reason this standard should not apply to catheter-based TAVR as well. The shorter the waiting period, the lower the morbidity and mortality<\/p>\n